[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

US Flu Vaccine Market to Amount to USD 2.5 Bn by 2022, States DPI Research in Its Topical Report Available at MarketPublishers.com

01 Mar 2017 • by Natalie Aster

LONDON – The US influenza (flu) vaccine market is poised to gain traction moving forward and be estimated at USD 2.5 billion by 2022.

The growth of the market is stimulated by an upsurge in awareness of the disease, increasing recommendations by government bodies and advisory committees to be immunised against the flu, and adoption of quadrivalent influenza vaccine (QIV).

GSK, Sanofi Pasteur, AstraZenecca, Seqirus, and Protein Sciences Corporation are some of the players taking the lead in the marketplace. Other emerging market participants, comprising Daiichi–Sankyo, Mitsubishi Tanabe Pharma, Novavax, VaxInnate, and BiondVax Pharmaceuticals Ltd, are making new technology-based flu vaccine which is anticipated to inmpact the market share in years to come.

Topical research study “United States Influenza Vaccine Market, Vaccination Analysis, Distribution, Production, Pipeline Insights, Clinical Trials, Deals Type, Regulatory, Price Trends, Competitive Strategies and Forecast, 2016 to 2022” elaborated by DPI Research & Marketing Solutions presents an all-encompassing, unbiased evaluation of the sector and includes keen insights, facts, historical figures, and highly reliable market data. It provides vital insights into USA flu vaccine market and projections. The study covers patterns of vaccination, doses distribution, manufacturing and provides a shrewd view of the regulatory setting. In addition, the report includes a deep analysis of clinical studies, pipeline and high-potential vaccines in US influenza vaccine sector. It canvasses key trends with respect to M&As, licensing agreements and collaborations. The publication profiles the dominant players in the influenza vaccine market, which comprise business overview, product outlook and an insightful analysis of sales of flu vaccines to 2022. A granular look at the major drivers and restraints of flu vaccine market is included, too.

More in-demand reports by this publisher are available at DPI Research & Marketing Solutions page.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]

Analytics & News

Weekly Digest